Stockscreener 앱 받기
89.60
0.95%
0.84
시간 외 거래:
89.60
전일 마감가:
$88.76
열려 있는:
$89.49
하루 거래량:
3.36M
Relative Volume:
0.60
시가총액:
$33.81B
수익:
$4.82B
순이익/손실:
$930.40M
주가수익비율:
38.32
EPS:
2.3381
순현금흐름:
$1.43B
1주 성능:
+0.08%
1개월 성능:
+16.89%
6개월 성능:
+23.08%
1년 성능:
+10.86%
1일 변동 폭
$88.98
$91.50
1주일 범위
$88.14
$91.96
52주 변동 폭
$54.11
$91.96
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
89.60 | 33.49B | 4.82B | 930.40M | 1.43B | 2.3381 |
ABT
Abbott Laboratories
|
112.68 | 190.98B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.37 | 127.22B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.09 | 115.97B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.47 | 74.53B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.98 | 52.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-24 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2026-01-12 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Dexcom stock edges higher as Q1 2026 growth and CGM demand support valuation - AD HOC NEWS
Flputnam Investment Management Co. Makes New Investment in DexCom, Inc. $DXCM - InsuranceNewsNet
Performance Wealth Partners LLC Takes Position in DexCom, Inc. $DXCM - MarketBeat
GSA Capital Partners LLP Takes $1.33 Million Position in DexCom, Inc. $DXCM - MarketBeat
Global Retirement Partners LLC Purchases Shares of 20,784 DexCom, Inc. $DXCM - MarketBeat
DexCom (DXCM) Stock May Trade At A 37% Discount On Cash Flow - Yahoo Finance
DexCom Inc (MIL:1DXCM) Stock Price, Trades & News - GuruFocus
DexCom Inc. stock underperforms Monday when compared to competitors - MarketWatch
Dexcom (NASDAQ: DXCM) legal chief sells stock under 10b5-1 plan - Stock Titan
DexCom (DXCM) Rebounds On Growth Hopes, Does It Look Fully Valued? - Yahoo Finance
Dexcom stock trades at premium valuation as margins improve and targets rise - AD HOC NEWS
Nippon Life Global Investors Americas Inc. Buys Shares of 53,400 DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. (DXCM): Investor Outlook on a Leading Medical Device Innovator with Strong Buy Ratings - DirectorsTalk Interviews
DexCom (DXCM) Stock Sees Modest Fair Value Lift After Q2 And Clinical Updates - Yahoo Finance
Bridgewater Advisors Inc. Invests $1.08 Million in DexCom, Inc. $DXCM - MarketBeat
43,005 Shares in DexCom, Inc. $DXCM Bought by SWS Partners - MarketBeat
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
Is Wall Street Bullish or Bearish on DexCom Stock? - Barchart.com
Dexcom Inc (DXCM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Dexcom (DXCM) director Augustinos donates 1,075 shares and reports 5,575 RSUs - Stock Titan
ETFs Investing in DexCom, Inc. Stocks - TradingView
Dexcom stock holds above $90 as strong Q2 2026 margins support a raised outlook - AD HOC NEWS
Here's How Much You'd Have If You Invested $1000 in DexCom a Decade Ago - Yahoo Finance
Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating - marketscreener.com
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches? - TradingView
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here? - TradingView
DexCom (DXCM) director Bridgette Heller sells 1,012 shares in planned trade - Stock Titan
Stronger Q2 Results and Higher 2026 Outlook Might Change The Case For Investing In DexCom (DXCM) - webull.com
E. Ohman J or Asset Management AB Has $7.62 Million Position in DexCom, Inc. $DXCM - MarketBeat
DexCom stock hits 52-week high at 87.85 USD By Investing.com - Investing.com UK
DexCom Inc (DXCM) Stock Up 3.4% and Still Undervalued -- GF Scor - GuruFocus
DexCom (NASDAQ:DXCM) Reaches New 1-Year HighWhat's Next? - MarketBeat
DexCom stock hits 52-week high at 87.85 USD - Investing.com
DexCom, Inc. (DXCM) Stock Analysis: Exploring The 10.25% Potential Upside For Investors - DirectorsTalk Interviews
Assenagon Asset Management S.A. Has $46.72 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Stock Position Lifted by Gradient Investments LLC - MarketBeat
DexCom, Inc. $DXCM Shares Sold by Pacer Advisors Inc. - MarketBeat
Beacon Investment Advisory Services Inc. Reduces Stake in DexCom, Inc. $DXCM - MarketBeat
Dexcom Inc (DXCM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DexCom Inc. Stock Sheds 4.9%, Underperforms Market - webull.com
DexCom, Inc. (NASDAQ:DXCM) Given Consensus Rating of "Moderate Buy" by Brokerages - marketbeat.com
DexCom Inc (DXCM) Shares Fall 4.9% -- What GF Score of 94 Tells Investors - GuruFocus
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DexCom, Inc. (DXCM) Stock Forecasts - Yahoo! Finance Canada
Rathbones Group PLC Reduces Holdings in DexCom, Inc. $DXCM - MarketBeat
Edgestream Partners L.P. Has $981,000 Holdings in DexCom, Inc. $DXCM - marketbeat.com
DexCom, Inc. (DXCM) Stock forecasts - Yahoo Finance Singapore
DexCom (NASDAQ:DXCM) Director Mark Foletta Sells 2,000 Shares - MarketBeat
DexCom Inc (DXCM) director’s family trust sells 4,000 shares under 10b5-1 plan - Stock Titan
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
자본화:
|
볼륨(24시간):